Poster: CML-125 Clinical Significance of Serum Prohibition in Chronic Myeloid Leukemia Patients on First-Line Tyrosine Kinase Inhibitors

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 22; p. S146
Main Authors Rakha, Nahed Moawad, Yassin, Heba A., Azzazi, Mohamed, Hegab, Hany M., Nabih, Nermeen A., Naguib, Mary G.
Format Journal Article
LanguageEnglish
Published 01.10.2022
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
DOI:10.1016/S2152-2650(22)00883-7